CIK 0001359931 · Non-accelerated filer<br>Smaller reporting company
Protara Therapeutics, Inc.
Sign in to watch- Ticker
- TARA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 204580525
- Phone
- 646-844-0337
- Business address
- 345 PARK AVENUE SOUTH, 3RD FLOOR, NEW YORK, NY, 10010
- Former names
- Protara Therapeutics, Inc., ArTara Therapeutics, Inc., PROTEON THERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-26 | Shefferman Jesse CEO and President | Gift | −1,700 | 976,853 | ||
| 2025-06-26 | Shefferman Jesse CEO and President | Gift | −3,400 | 973,453 | ||
| 2025-06-24 | Shefferman Jesse CEO and President | Gift | −300,000 | 659,886 | ||
| 2025-06-12 | Solomon Michael Edward Director | Grant or award · Stock Option (Right to Buy) | +24,000 | 24,000 | ||
| 2025-06-12 | Smith Cynthia Director | Grant or award · Stock Option (Right to Buy) | +24,000 | 24,000 | ||
| 2025-06-12 | SARGEN GREGORY Director | Grant or award · Stock Option (Right to Buy) | +24,000 | 24,000 | ||
| 2025-06-12 | Levy Richard S Director | Grant or award · Stock Option (Right to Buy) | +24,000 | 24,000 | ||
| 2025-06-12 | Huang Jane Director | Grant or award · Stock Option (Right to Buy) | +24,000 | 24,000 | ||
| 2025-06-12 | GARCEAU ROGER Director | Grant or award · Stock Option (Right to Buy) | +24,000 | 24,000 | ||
| 2025-06-12 | Flannelly Barry P Director | Grant or award · Stock Option (Right to Buy) | +24,000 | 24,000 | ||
| 2025-06-12 | BESHAR LUKE M Director | Grant or award · Stock Option (Right to Buy) | +24,000 | 24,000 | ||
| 2025-06-02 | CONKLING WILLIAM Chief Commercial Officer | Grant or award | +50,000 | 50,000 | ||
| 2025-06-02 | CONKLING WILLIAM Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +200,000 | 200,000 | ||
| 2025-05-14 | Levy Richard S Director | Purchase | +20,000 | $3.19 | $64K | 51,000 |
| 2025-05-14 | Levy Richard S Director | Purchase | +20,000 | $3.19 | $64K | 51,000 |
| 2025-04-15 | Nicacio Leonardo Viana Chief Medical Officer | Grant or award | +50,000 | 52,181 | ||
| 2025-04-15 | Nicacio Leonardo Viana Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2025-03-26 | Zummo Jacqueline Chf Scientific Operations Off | Sale 10b5-1 | −21,224 | $4.53 | $96K | 98,861 |
| 2025-01-24 | Shefferman Jesse CEO and President | Grant or award | +65,000 | 994,022 | ||
| 2025-01-24 | Shefferman Jesse CEO and President | Grant or award · Stock Option (Right to Buy) | +387,000 | 387,000 |
Page 3 of 8 · 154 trades